Susquehanna International Group’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16
Closed -$3.02K 13325
2022
Q4
$2.28K Sell
16
-54
-77% -$23.4K ﹤0.01% 12122
2022
Q3
$35K Buy
70
+20
+40% +$17.4K ﹤0.01% 12398
2022
Q2
$43K Buy
50
+11
+28% +$15.1K ﹤0.01% 12056
2022
Q1
$99K Sell
39
-12
-24% -$28.5K ﹤0.01% 11925
2021
Q4
$132K Sell
51
-2
-4% -$8K ﹤0.01% 11937
2021
Q3
$244K Sell
53
-180
-77% -$1.22M ﹤0.01% 11057
2021
Q2
$1.6M Sell
233
-60
-20% -$414K ﹤0.01% 6465
2021
Q1
$2.15M Buy
293
+211
+257% +$1.77M ﹤0.01% 5752
2020
Q4
$661K Buy
82
+39
+91% +$351K ﹤0.01% 7670
2020
Q3
$436K Buy
43
+4
+10% +$32.8K ﹤0.01% 7956
2020
Q2
$265K Buy
39
+16
+70% +$110K ﹤0.01% 8573
2020
Q1
$105K Sell
23
-40
-63% -$200K ﹤0.01% 9289
2019
Q4
$380K Sell
63
-12
-16% -$76.7K ﹤0.01% 7530
2019
Q3
$530K Buy
+75
New +$546K ﹤0.01% 7178

Other funds holding RDHL

Susquehanna International Group's RDHL Position: Q1 2023 in Review

Susquehanna International Group sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 16 shares — an estimated $3.02K sold.

Susquehanna International Group first reported a position in RDHL in Q3 2019 and held it in 14 quarters. The position peaked at $2.15M in Q1 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Susquehanna International Group reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 16 Redhill Biopharma shares in Q1 2023, an estimated $3.02K.
  • Susquehanna International Group first reported a position in Redhill Biopharma in Q3 2019 and held it in 14 quarters.
  • Susquehanna International Group's Redhill Biopharma position peaked at $2.15M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.